Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: Q4Q8H7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.527 |
CLV_NRD_NRD_1 | 149 | 151 | PF00675 | 0.570 |
CLV_NRD_NRD_1 | 227 | 229 | PF00675 | 0.589 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.625 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.492 |
CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.646 |
CLV_PCSK_FUR_1 | 104 | 108 | PF00082 | 0.603 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.517 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.570 |
CLV_PCSK_KEX2_1 | 271 | 273 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 278 | 280 | PF00082 | 0.565 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.642 |
CLV_PCSK_PC1ET2_1 | 106 | 108 | PF00082 | 0.536 |
CLV_PCSK_PC1ET2_1 | 271 | 273 | PF00082 | 0.507 |
CLV_PCSK_PC1ET2_1 | 278 | 280 | PF00082 | 0.565 |
CLV_PCSK_PC7_1 | 102 | 108 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 223 | 227 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.434 |
CLV_Separin_Metazoa | 261 | 265 | PF03568 | 0.450 |
DEG_APCC_DBOX_1 | 83 | 91 | PF00400 | 0.481 |
DOC_MAPK_gen_1 | 104 | 112 | PF00069 | 0.515 |
DOC_MAPK_gen_1 | 186 | 196 | PF00069 | 0.514 |
DOC_MAPK_gen_1 | 37 | 46 | PF00069 | 0.496 |
DOC_MAPK_MEF2A_6 | 189 | 198 | PF00069 | 0.526 |
DOC_MAPK_MEF2A_6 | 37 | 46 | PF00069 | 0.496 |
DOC_MAPK_NFAT4_5 | 39 | 47 | PF00069 | 0.513 |
DOC_MAPK_RevD_3 | 27 | 40 | PF00069 | 0.407 |
DOC_PP1_RVXF_1 | 37 | 44 | PF00149 | 0.486 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.397 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.648 |
LIG_14-3-3_CanoR_1 | 207 | 211 | PF00244 | 0.463 |
LIG_14-3-3_CanoR_1 | 231 | 235 | PF00244 | 0.543 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.624 |
LIG_14-3-3_CterR_2 | 285 | 290 | PF00244 | 0.499 |
LIG_Actin_WH2_2 | 123 | 141 | PF00022 | 0.481 |
LIG_Actin_WH2_2 | 191 | 209 | PF00022 | 0.471 |
LIG_Actin_WH2_2 | 255 | 273 | PF00022 | 0.503 |
LIG_APCC_ABBAyCdc20_2 | 39 | 45 | PF00400 | 0.493 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.602 |
LIG_Clathr_ClatBox_1 | 41 | 45 | PF01394 | 0.493 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.532 |
LIG_FHA_1 | 183 | 189 | PF00498 | 0.532 |
LIG_FHA_2 | 177 | 183 | PF00498 | 0.424 |
LIG_FHA_2 | 197 | 203 | PF00498 | 0.491 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.627 |
LIG_LIR_Gen_1 | 185 | 194 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 185 | 190 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 236 | 242 | PF02991 | 0.514 |
LIG_LIR_Nem_3 | 273 | 277 | PF02991 | 0.538 |
LIG_LRP6_Inhibitor_1 | 31 | 37 | PF00058 | 0.444 |
LIG_NRBOX | 258 | 264 | PF00104 | 0.448 |
LIG_PCNA_PIPBox_1 | 155 | 164 | PF02747 | 0.398 |
LIG_SH2_CRK | 239 | 243 | PF00017 | 0.509 |
LIG_SH2_GRB2like | 97 | 100 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 275 | 278 | PF00017 | 0.555 |
LIG_SH3_3 | 281 | 287 | PF00018 | 0.651 |
LIG_SH3_3 | 60 | 66 | PF00018 | 0.675 |
LIG_SUMO_SIM_anti_2 | 28 | 33 | PF11976 | 0.454 |
LIG_TRAF2_1 | 253 | 256 | PF00917 | 0.499 |
LIG_TRAF2_1 | 69 | 72 | PF00917 | 0.514 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.538 |
MOD_CK2_1 | 176 | 182 | PF00069 | 0.429 |
MOD_CK2_1 | 218 | 224 | PF00069 | 0.494 |
MOD_CK2_1 | 230 | 236 | PF00069 | 0.592 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.635 |
MOD_GlcNHglycan | 245 | 248 | PF01048 | 0.391 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.646 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.481 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.379 |
MOD_N-GLC_1 | 218 | 223 | PF02516 | 0.452 |
MOD_NEK2_1 | 270 | 275 | PF00069 | 0.440 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.631 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.464 |
MOD_PKA_2 | 230 | 236 | PF00069 | 0.470 |
MOD_Plk_1 | 223 | 229 | PF00069 | 0.460 |
MOD_Plk_1 | 58 | 64 | PF00069 | 0.618 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.650 |
MOD_SUMO_rev_2 | 267 | 273 | PF00179 | 0.480 |
MOD_SUMO_rev_2 | 33 | 42 | PF00179 | 0.475 |
MOD_SUMO_rev_2 | 85 | 90 | PF00179 | 0.459 |
TRG_DiLeu_BaEn_4 | 171 | 177 | PF01217 | 0.466 |
TRG_DiLeu_BaEn_4 | 254 | 260 | PF01217 | 0.494 |
TRG_DiLeu_BaEn_4 | 71 | 77 | PF01217 | 0.490 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.513 |
TRG_ENDOCYTIC_2 | 274 | 277 | PF00928 | 0.508 |
TRG_ER_diArg_1 | 101 | 104 | PF00400 | 0.594 |
TRG_ER_diArg_1 | 149 | 152 | PF00400 | 0.519 |
TRG_ER_diArg_1 | 166 | 169 | PF00400 | 0.486 |
TRG_ER_diArg_1 | 74 | 76 | PF00400 | 0.651 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IM76 | Leptomonas seymouri | 54% | 93% |
A0A1X0NYF4 | Trypanosomatidae | 33% | 97% |
A0A3S7X1C2 | Leishmania donovani | 92% | 96% |
A4HGD4 | Leishmania braziliensis | 70% | 94% |
A4I3G7 | Leishmania infantum | 92% | 96% |
E9AZQ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 96% |